Morgan Stanley Connect Biopharma Holdings LTD Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
A detailed history of Morgan Stanley transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Morgan Stanley holds 3,568 shares of CNTB stock, worth $3,746. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,568Holding current value
$3,746% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding CNTB
# of Institutions
13Shares Held
3.03MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.09MShares$2.2 Million1.77% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$536,2360.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny212KShares$222,9150.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$109,0850.0% of portfolio
-
Callan Capital, LLC La Jolla, CA41.8KShares$43,9140.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $57.8M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...